Journal of Clinical & Experimental Pharmacology

International Conference and Exhibition on Pharmacovigilance & Clinical Trials

October 1-3, 2012 DoubleTree by Hilton Chicago-North Shore, USA

Scientific Tracks Abstracts

• Minimizing reconciliation between safety and clinical databases

  Sean Neal

  PDF HTML

• FDA final rule on IND safety reporting: What study sponsors should know?

  Sally Van Doren

  PDF HTML

• Death after quadrivalent human papillomavirus (qHPV) vaccination: Causal or coincidental?

  Lucija Tomljenovic

  PDF HTML

• Experiences of active pharmacovigilance in patients of Colombia

  Jorge E. Machado-Alba

  PDF HTML

• A retrospective study on detecting signals about traditional Chinese medicine adverse drug reaction with pharmacovigilance analyzing methods

  Yanming Xie

  PDF HTML

• Evaluation of SENSORIL�-Withania somnifera - on biomarkers and mental stress test induced cardiovascular changes in healthy human participants

  Pingali Usharani

  PDF HTML

• Effects of acute and chronic maternal separation and alcohol intake on adolescent rats

  Gabriela Beatriz Acosta

  PDF HTML

• Is HIV infection curable?

  A.A Onifade

  PDF HTML

• Pharmacokinetics bases of adverse drug-drug interactions

  Pankaj B. Desai

  PDF HTML

• Is it safe to breast feed her child when the mother received opioid analgesic drugs?

  Raphael Serreau

  PDF HTML

• Ethical standards of Indian clinical trials are not getting diluted

  Pingali Usharani

  PDF HTML

• Role of pharmacogenetics in adverse drug reactions

  Nimita Dave

  PDF HTML

• A series of registry studies on safety surveillance of seven post-marketing Chinese medicine injections in mainland China: Protocol

  Xing Liao

  PDF HTML

• Prospective analysis of actively screened adverse drug reaction profile presented into the inward set up in government tertiary hospital in Sri Lanka

  Hettihewa LM

  PDF HTML

• Pharmacovigilance of drug interactions in patients of Colombia

  Jorge E. Machado-Alba

  PDF HTML

• Predictors of pharmacist�s reporting of serious adverse drug events to the Food and Drug Administration

  Paul Gavaza

  PDF HTML

• Natural polyphenol supplements offering possible remediation to paraben intoxication

  Komal H Shah

  PDF HTML

• Polygonum bistorta and its active principle against hepatotoxicity

  Deepak Kumar Mittal

  PDF HTML